Fast Imaging for Hyperpolarized MR Metabolic Imaging
- 10 February 2020
- journal article
- review article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 53 (3) , 686-702
Abstract
MRI with hyperpolarized carbon‐13 agents has created a new type of noninvasive, in vivo metabolic imaging that can be applied in cell, animal, and human studies. The use of 13C‐labeled agents, primarily [1‐13C]pyruvate, enables monitoring of key metabolic pathways with the ability to image substrate and products based on their chemical shift. Over 10 sites worldwide are now performing human studies with this new approach for studies of cancer, heart disease, liver disease, and kidney disease. Hyperpolarized metabolic imaging studies must be performed within several minutes following creation of the hyperpolarized agent due to irreversible decay of the net magnetization back to equilibrium, so fast imaging methods are critical. The imaging methods must include multiple metabolites, separated based on their chemical shift, which are also undergoing rapid metabolic conversion (via label exchange), further exacerbating the challenges of fast imaging. This review describes the state‐of‐the‐art in fast imaging methods for hyperpolarized metabolic imaging. This includes the approach and tradeoffs between three major categories of fast imaging methods—fast spectroscopic imaging, model‐based strategies, and metabolite specific imaging—as well additional options of parallel imaging, compressed sensing, tailored RF flip angles, refocused imaging methods, and calibration methods that can improve the scan coverage, speed, signal‐to‐noise ratio (SNR), resolution, and/or robustness of these studies. To date, these approaches have produced extremely promising initial human imaging results. Improvements to fast hyperpolarized metabolic imaging methods will provide better coverage, SNR, resolution, and reproducibility for future human imaging studies.Level of Evidence: 5Technical Efficacy Stage: 1Keywords
Funding Information
- American Cancer Society (RSG‐18‐005‐01‐CCE)
- The National Cancer Institute (R01CA211150, U01 CA232320)
- National Institute of Biomedical Imaging and Bioengineering (U01 EB026412, P41 EB013598)
- Queensland Brain Institute
- National Institutes of Health (U01EB026412, U01CA232320, R01CA211150, P41 EB013598)
This publication has 111 references indexed in Scilit:
- Hyperpolarized 13 C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imagingProceedings of the National Academy of Sciences, 2011
- Imaging of blood flow using hyperpolarized [13C]Urea in preclinical cancer modelsJournal of Magnetic Resonance Imaging, 2011
- T2relaxation times of13C metabolites in a rat hepatocellular carcinoma model measuredin vivousing13C-MRS of hyperpolarized [1-13C]pyruvateNMR in Biomedicine, 2010
- 3D compressed sensing for highly accelerated hyperpolarized 13C MRSI with in vivo applications to transgenic mouse models of cancerMagnetic Resonance in Medicine, 2009
- Production of hyperpolarized [1,4- 13 C 2 ]malate from [1,4- 13 C 2 ]fumarate is a marker of cell necrosis and treatment response in tumorsProceedings of the National Academy of Sciences, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C‐pyruvateMagnetic Resonance in Medicine, 2009
- Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic productsJournal of Magnetic Resonance, 2008
- Real-time metabolic imagingProceedings of the National Academy of Sciences, 2006
- Iterative decomposition of water and fat with echo asymmetry and least‐squares estimation (IDEAL): Application with fast spin‐echo imagingMagnetic Resonance in Medicine, 2005